Risk of Acute Myocardial Infarction and Stroke among Carbidopa/Levodopa, Entacapone, and Carbidopa/Levodopa/Entacapone Users

Project Title Risk of Acute Myocardial Infarction and Stroke among Carbidopa/Levodopa, Entacapone, and Carbidopa/Levodopa/Entacapone Users
Date Posted
Tuesday, March 27, 2018
Project ID
MSY2_MP3T2
Status
Complete
Deliverables
Description

This report investigates acute myocardial infarction (AMI) and stroke among users of entacapone, combination carbidopa/levodopa, and combination carbidopa/levodopa/entacapone (Stalevo) with Parkinson’s Disease in the Mini-Sentinel Distributed Database (MSDD). The package was distributed to Partners on February 24, 2011.

Medical Product
carbidopa/levodopa
carbidopa/levodopa/entacapone (Stalevo)
entacapone
Population / Cohort
All individuals with Parkinson's DIsease
Time Period
January 1, 2000 - December 31, 2010
Assessment Type
Exploratory Analyses
Study Type
Modular Program
Data Sources
Mini-Sentinel Distributed Database (MSDD)
FDA Center
CDER